TopAuthor Guidelines

Did you know... Journal of Neurochemistry has no page charges?

Instructions to Authors

Online submission and a summary of instructions for submission of manuscripts online are available at:

ScholarOne (formerly known as Manuscript Central) http://mc.manuscriptcentral.com/jneurochem

I. GENERAL

1. Submission online ensures rapid review and allows online manuscript tracking. Full instructions and support are available online and also from the Journal of Neurochemistry submission site.

If in doubt, contact the Editorial Coordinator in Seattle or the Editorial Coordinator in Leeds.

2. The Journal is a leading source for research into all aspects of neurobiology and is devoted to the prompt publication of original findings of the highest scientific priority and value. While manuscripts that are entirely clinical, wholly pharmacological, histochemical, or immunological, and methods papers or the cloning of confirmatory sequences are not normally considered, these authors are encouraged to discuss a potential submission with one of the Chief Editors by e-mail.

Papers that require extensive revision or further experimentation will be rejected. When revision is invited, resubmission must be performed within one (minor) or 3 months (major).

3. Two types of papers are considered: (a) Original Articles (full papers) should be written in the style described in section III. The more concise and well written a paper, the more rapidly it will be processed. (b) Reviews are usually invited but unsolicited reviews can be considered and will be subjected to rigorous editorial assessment. It is recommended to send first a synopsis to the Editor for Reviews.

4. Submission of a paper to JNC will be held to imply that it represents original research not previously published (except as an abstract or preliminary report), that it is not being considered for publication elsewhere, and that, if accepted, it will not be published elsewhere in similar form, in any language, without the consent of the International Society for Neurochemistry. Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published.

The corresponding author should be prepared to explain the inclusion of individuals and to take responsibility for the integrity of the work as a whole, from inception to published article.

5. All authors are expected to abide by accepted ethical standards. All studies using human or animal subjects should include an explicit statement identifying the Institution or Review Committee which approved the study. The Materials and Methods section must briefly but explicitly state measures which were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the relevant National Agency. When human subjects are used, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject, and that the study conforms with The Code of Ethics of the World Medical Association (Declaration of Helsinki), printed in the British Medical Journal (18 July 1964). Editors reserve the right to reject papers if there is doubt whether appropriate procedures were followed.

6. Publication of descriptions of new recombinant nucleic acid or monoclonal antibody preparations will be on the understanding that the authors are willing to supply samples of such materials in response to reasonable scientific requests.

7. Peer-reviewed articles are normally published online within 5 working days of receipt at the Production Office after acceptance, prior to their being copy-edited and proofed.

8. JNC is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in an issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After issue publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at: http://www.doi.org/index.html

9. Colour artwork in JNC is published free of charge to the author, both online and in print.

II. SUBMISSION OF PAPERS

Original Articles and Reviews should be submitted online. For reviewing purposes, the journal prefers to receive a single PDF file containing both the text and the figures.

Manuscript submission online can be in Word document (.doc), Rich Text Format (.rtf), Portable Document Format (.pdf) or PostScript (.ps), provided that the figures are embedded in the text (or at the end of it) and are clearly numbered. Each of these file formats will be converted automatically to a single low-resolution PDF for reviewing purposes. It is important that you submit your manuscript either as a PDF file containing figures or as individual files of the text and figures which will be automatically converted to a PDF file for review. Please do not upload both PDF file and separate manuscript files. It is imperative that the author reviews the converted PDF file as it will be seen by the referees. If you have any questions or wish to make changes to your submitted manuscript please contact the editorial coordinator in Seattle or Leeds.

Figures can be embedded in the native word processor file at the end of the text after the Legends to Figures or may be uploaded separately in one of the following formats: TIFF, EPS. Figures uploaded separately in these file formats will be automatically converted to small jpegs for reviewing. High resolution figures will be requested on acceptance if not supplied already. Detailed information on our digital illustration standards is available on the Wiley-Blackwell website, http://authorservices.wiley.com/bauthor/illustration.asp.

1. Authors should look online at the list of handling editors (HE) and select one or more appropriate individuals. If you have no preference please indicate so in the online prompt. The geographical location of the HE will determine which Chief Editor (CE) communicates with the corresponding author.

2. Reviews should be submitted online to Sean Murphy who will reassign it to the Deputy Chief Editor for Reviews.

3. Authors must suggest the names of at least three potential reviewers when a manuscript is submitted.

III. MANUSCRIPT REQUIREMENTS

1. Lay-out of Original Articles (a) Manuscripts that are judged to be longer than 10 journal pages (including figures and tables) will be returned to the authors for shortening without review, unless valid justification is provided. 10 journal pages is equivalent to 10,000 words which must however be reduced proportionately to allow for figures and tables (which on average fill half a page each). Concise well-written papers are generally processed more quickly than long ones. Ancillary data should be published online only as supporting information.

(b) Manuscripts should be double-spaced throughout and with margins at least 2.5 cm wide.

(c) Each manuscript must have a title page that includes only the title, authors names, laboratory of origin, name, address, telephone and fax numbers, and must include the email address of the person to whom proofs and reprint requests should be addressed, and any necessary footnotes, including one defining abbreviations used in the text (see 7c). Indicate specific affiliations of each author. Information concerning sources of financial support and a statement declaring any/no conflict of interest must be placed in an Acknowledgment section, between Discussion and References. A competing interest exists when professional judgement concerning a primary interest (such as the validity of research) may be influenced by a secondary interest (such as financial gain). Any competing interest should be acknowledged and openly stated in the cover letter and at the end of the manuscript, together with the sources of funding for the work described. For further information on what should be declared please see the BMJ declaration and corresponding BMJ editorial - Beyond conflict of interest (BMJ 1998;317:291 - 2).

(d) The page following the title page should include a brief abstract (see 4a), up to six keywords, and a running title not exceeding 45 characters in length. Please do pay particular attention to the title and abstract of your manuscript to optimize these for A&I keyword searches, see http://authorservices.wiley.com/bauthor/seo.asp; Editors reserve the right to suggest modification.

(e) Manuscripts should not be numbered in series, but subtitles are acceptable.

(f) Pages should be numbered in succession, the title page being page 1.

(g) Each table should be on a separate page at the end of the manuscript, followed by a page of figure legends.

(h) Footnotes to the text should be used sparingly, should be indicated by superscript numbers, and typed with corresponding numbers on a separate sheet. In Tables, reference to footnotes should be made with superscript lowercase letters.

(i) Drug names should be the official or approved names; trade names or common names may be given in brackets where the drug is first mentioned.

(j) The IUB Enzyme Commission (EC) number must be quoted with the full name of the enzyme when it is first mentioned in the text. Subsequently the accepted trivial name shall be used, e.g. full name: Acetyl-CoA, choline O-acetyltransferase (EC 2.3.1.6), trivial name: choline acetyltransferase not choline acetylase. For this information the author should refer to Enzyme Nomenclature (1992), Academic Press, San Diego and London. (Units of enzyme activity should be defined in terms of the rate of the reaction catalyzed under specified conditions.) The official Système Internationale (SI) unit is the katal, i.e. mol of substrate transformed (or product formed)/s. However, it may be expressed in other terms, provided clear definitions are given, e.g. µmol/s or µmol/min.

(k) Solutions. Although SI recommends concentrations to be expressed as mol/L rather than M and that % (wt/vol) and % (vol/vol) should be given as g/L and mL/L, respectively, the use of M, % (wt/vol), and % (vol/vol) will be allowed. N is not permitted. Fractional concentrations should be expressed in decimal form.

(l) Centrifugation conditions should be expressed in terms of g and time; not in revolutions per minute.

2. Form for Reviews

Reviews should not occupy more than 14 printed pages of the journal and should be authoritative and topical accounts of the subject area

3. Style

(a) Manuscripts should be concisely written in a readily understandable style. Technical neologisms, laboratory slang or words not defined in dictionaries should not be used.

(b) Redundant words, phrases and sentences should not be used. The captions of Tables and Figures, with or without paraphrasing, should not be repeated in the text. The Editors reserve the right to revise the wording of manuscripts accepted for publication in the Journal.

Authors should familiarize themselves with the double-column format and style of recently published papers.

4. Organization

(a) Each paper must begin with a brief Abstract. It should not exceed 200 words. Only the abbreviations allowed without definition (see 7b) may be used in the abstract.

(b) An introductory statement should give the reasons for undertaking the investigation and a summary of the experimental plan. Exhaustive reviews of the literature should be avoided.

(c) Experimental procedures or Materials and methods. Special chemicals etc. with their sources should be grouped under a separate subheading Materials. Procedures should be given in sufficient detail to permit the repetition of the work by others. Published procedures should be summarized, but not described in detail unless they have been substantially modified. If the procedures used are described in detail in articles that are in press, copies of such unpublished articles must accompany the submitted manuscript.

(d) Results. The findings should be described without discussion of their significance. Experimental conclusions should normally be based on an adequate number of observations with statistical analysis of variance and the significance of differences. (See 5f.)

(e) Discussion. The significance of the findings should be assessed in relation to the status of the field.

5. Presentation of Data in Tables or Figures

Supporting information is peer-reviewed material directly relevant to the conclusions of an article that cannot be included in the published version owing to space or format constraints. It is posted on the journal's web site and linked to the article when the article is published and may consist of additional text, figures, tables, multimedia files or datasets. The published article must be complete and self-explanatory without the supplementary information. Supplementary information should enhance, but not be essential to, a reader's understanding of the paper.

Wherever possible please ensure that multiple instances and formats of supporting information (tables, figures and appendices) are contained within one, single submitted document.

(a) Tables and Figures should be constructed so that they, together with their captions and legends, will be intelligible with minimal reference to the text. Use the table function of a word processor rather than tabs and spaces. Authors should carefully consider whether the content of a particular Table or Figure is best displayed in the body of the text or could be included as Supporting information.

Supporting information such as video clips can be made available in the online Journal, and can be submitted online with RTF manuscripts [complete instructions can be found in the author center of the journal's ScholarOne (formerly known as Manuscript Central) site and here].

(b) Only in exceptional cases may the same data be published in a Table and a Figure.

(c) Each column of a Table should carry an appropriate heading.

(d) The units of measurement must be indicated clearly in the column headings of a Table or the coordinates of a Figure. If the unit of measurement is the same for all the data in a Table, it may be given in the caption or in a line to be printed immediately below the Table.

(e) Each Figure must be accompanied by an explanatory but concise legend. The legends should be listed on a separate page(s) at the end of the manuscript before the figures. Explain all symbols used in the figuresheet for each legend. Explain all symbols used in the Figure. Follow the instructions for submitting figures with RTF manuscripts. Please insert tags to indicate where each figure is to be placed in the manuscript.

(f) Data should be presented as clearly defined mean values with some measure of their dispersion (e.g. standard deviation or standard error, and range) and an indication, with appropriate symbols, of the statistical significance of differences from control values (e.g. *p

(g) The Publisher guarantees to reproduce electron micrographs to the satisfaction of the author. Figures should normally be about twice the final size; in no case should the dimensions exceed 20 x 30 cm. All lettering should be large enough to be legible when reduced to single-column size.

(h) Data may be presented in bar graphs where appropriate. However, three-dimensional presentation is acceptable only for data with three variants.

(i) Figures must be planned so as to avoid wasted white space. It is not necessary for the scale on a coordinate to start at 0.

(j) Authors are requested to use scale bars on micrographs.

(k) When a manuscript has been accepted, you will be requested to upload high-resolution figures to ScholarOne Manuscripts (formerly known as Manuscript Central). At this stage, the corresponding author should submit documentation or explanation of any image enhancement used. The editors reserve the right to request submission of original unprocessed data from authors should questions arise about the appropriateness of any image enhancement. Authors should suggest images that might be used on the journal cover.

6. References (a) In the text, cite references by names of authors and year of publication. At the end of the paper, references should be listed in alphabetical order, except for papers by three or more authors, which should be grouped in chronological order after any other papers by the first author. Names of all co-authors must be given followed by the year of publication, full title of the paper, name of the Journal (see below) and first and last page numbers. Where papers are written by ten or more or more authors, please list the first three authors then et al.

Examples

Journal article: Fassbender K., Simons M., Bergmann C. et al (2001) Simvastin strongly reduces levels of Alzheimers disease ß-amyloid peptides Aß42 and Aß40 in vitro and in vivo. Proc. Natl Acad. Sci. USA 98, 5856-5861.

Chapter in book: Feenstra M. G. P. (2000) Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward, in Progress in Brain Research, (Uylings H. B. M., Van Eden C. G., De Bruin J. P. C., Feenstra M. G. P. and Pennartz C. M. A., eds), Vol. 126, pp. 133-163. Elsevier Science B. V., Amsterdam.

Book: Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.

Book in series: Di Chiara G. and Gessa G. L., eds (1981) Advances in Biochemical Psychopharmacology, Vol. 27: Glutamate as a Neurotransmitter. Raven Press, New York.

Journal titles should be abbreviated in accordance with the List of Journals Indexed in Index Medicus (Superintendent of Documents, US Government Printing Office, Washington, DC 20402, USA, DHEW Publication No. 95-267).

Acta Neurol. Scand. Acta Physiol. Scand. Anal. Biochem. Arch. Biochem. Biophys. Biochem. J. Biochem. Pharmacol. Biochim. Biophys. Acta Biol. Chem. Hoppe Seyler Br. J. Pharmacol. Eur. J. Pharmacol. Experientia J. Biol. Chem. J. Cell Biol. J. Mol. Biol. J. Pharmacol. Exp. Ther. J. Physiol. (Lond.) Mol. Pharmacol. Nature Proc. Natl Acad. Sci. USA Proc. Soc. Exp. Biol. Med. Science

(b) Unpublished experiments, papers in preparation, etc., may be mentioned only in the text; they must not be included in the list of References.

(c) A paper that has been accepted for publication may be cited in the References with the abbreviated name of the Journal followed by the words, in press. The date of acceptance of each such paper should be indicated when the manuscript is submitted. If reference is made to papers in press (or submitted), such items must be uploaded online and labelled as 'supporting document, for information'.

(d) Personal communications may be used only when written authorization from the communicator is submitted with the original manuscript; they may be mentioned only in the text, giving name of communicator.

7. Abbreviations and Symbols

(a) The use of abbreviations should be restricted to the Système Internationale (SI) units, see Biochem. J. (1978) 169, 1-27, and a minimum of other generally accepted terms [see (b)]. Excessive use of abbreviations in the text is discouraged.

(b) The following abbreviations may be used without definition.

ADP, CDP, GDP, IDP, UDP, 5(pyro)-diphosphates of adenosine, cytidine, guanosine, inosine, and uridine AMP, etc.-5-phosphates of adenosine, etc. ANOVA, analysis of variance ATP, etc.-5`(pyro)-triphosphates of adenosine, etc. ATPase, adenosine triphosphatase bp, base pair Ci, curie CoA and acyl-CoA-coenzyme A and its acyl derivatives (e.g., acetyl-CoA) cpm, counts per minute CNS, central nervous system CSF, cerebrospinal fluid Cyclic AMP, 3,5-cyclic adenosine monophosphate Cyclic GMP-3,5-cyclic guanosine monophosphate DNA, deoxyribonucleic acid DNase, deoxyribonuclease DOPA, 3,4-dihydroxyphenylalanine dpm, dps-disintegrations per minute, disintegrations per second EDTA, ethylene-diaminetetraacetate EEG, electroencephalogram EGTA, ethyleneglycol bis(aminoethylether)tetraacetate ELISA, enzyme-linked immunosorbent assay FAD, FADH2, flavin-adenine dinucleotide and its reduced form FMN, flavin mononucleotide g, average gravity GABA, gamma-aminobutyric acid (not Gaba) GLC, gas-liquid chromatography GSSG, GSH, glutathione, oxidized and reduced forms h, hour HEPES, N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid HPLC, high performance liquid chromatography Ig, immunoglobulin IR, infrared kb, kilobase kDa, kilodalton µm, micron min, minute MPP+, 1-methyl-4-phenylpyridinium MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine NAD+, NADH-oxidized and reduced forms of nicotin-amide-adenine dinucleotide NADP+, NADPH-oxidized and reduced forms of nicotin-amide-adenine dinucleotide phosphate NAD, NADP may be used when the oxidation state need not be indicated NMDA, N-methyl-D-aspartate NMN, nicotinamide mononucleotide NMR, nuclear magnetic resonance PCR, polymerase chain reaction Pi, orthophosphate (inorganic) PNS, peripheral nervous system PPi, pyrophosphate (inorganic) rpm, revolutions per minute RNA, ribonucleic acid RNase, ribonuclease RT, reverse transcription s, second SEM, standard error of mean SD, standard deviation TLC, thin-layer chromatography Tris, 2-amino-2-hydroxymethylpropane-1,3-diol UV, ultraviolet

(c) Other abbreviations may be used sparingly and defined in a footnote on the title page, as well as at their first mention in text. Recommended forms of abbreviation to be used with definition are as follows.

ACh, acetylcholine AChE, acetylcholinesterase AMPA, alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate ChAT, choline acetyltransferase COMT, catechol-O-methyltransferase DA, 3,4-dihydroxyphenylethylamine or dopamine 5-HT, 5-hydroxytryptamine or serotonin MAO, monoamine oxidase NA, noradrenaline, norepinephrine NeuNAc, N-acetylneuraminic acid (not NANA)

(d) Abbreviations should not be used in titles and running titles.

8. Nomenclature

As far as possible, authors should follow the recommendations of the IUPAC-IUB Joint Commission on Biochemical Nomenclature. For references to these rules see Biochemical Nomenclature and Related Documents 2nd edit. (1992), available from Portland Press Ltd., 59 Portland Place, London W1N 3AJ, UK or Portland Press Inc., PO Box 2191, Chapel Hill, NC 27515-2191, USA.

9. Protein Sequences

Protein sequences, which have been determined by direct sequencing of the protein, must be submitted to SWISS-PROT at the EMBL Outstation - The European Bioinformatics Institute. Please note that we do not provide accession numbers, IN ADVANCE, for protein sequences that are the result of translation of nucleic acid sequences. These translations will automatically be forwarded to us from the EMBL nucleotide database and are assigned SWISS-PROT accession numbers on incorporation into TrEMBL.

Results from characterization experiments should also be submitted to SWISS-PROT at the EBI. This can include such information as function, subcellular location, subunit etc.

Contact information: SWISS-PROT Submissions, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. Tel: +44 (0)1223 494400; Fax: +44 (0)1223 494472. Email: datasubs@ebi.ac.uk (for sequence admissions) update@ebi.ac.uk (for characterization information) Website: www.ebi.ac.uk

10. Revision

Review of revised papers by editors and referees will be facilitated if a summary of the changes is supplied in a letter with specific reference to the comments of editors and referees. The revised manuscript should clearly show changes. When submitting a REVISED manuscript, a form is provided online with boxes for comments to the Editor and for referees. These comments MUST be submitted BEFORE the revised manuscript is uploaded [instructions are provided on the online submission site ScholarOne (formerly known as Manuscript Central) http://mc.manuscriptcentral.com/jneurochem].

When the paper is accepted, we shall need your artwork in electronic form. This can be done when the revision is submitted. In this case, please upload separately the text of the manuscript and the figures. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript Format (EPS), and bitmap files (e.g. halftones) in Tagged Image File Format (TIFF). Ideally vector graphics that have been saved in metafile (.WMF) or pict (.PCT) format should be embedded within the body of the text file. Click here for detailed information on our digital illustration standards.

11. Proofs

All information about the proofs will be sent to the author submitting the paper and corrected proofs must be returned promptly. This will allow correction of typesetters and similar errors. Major changes will not be entertained and authors may be charged for excessive amendments at this stage. Authors will be sent an e-mail alerting them that proofs are available to download from our secure designated author website. Authors who fail to download the proofs will be sent their proofs via e-mail as an Acrobat PDF (portable document format) file. Therefore, the corresponding author should supply their e-mail address when they submit their manuscript. The e-mail server must be able to accept attachments up to 4 MB in size. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following Web site:

http://www.adobe.com/prodindex/acrobat/main.html

To assure prompt publication, proofs should be returned not more than 3 working days after receipt. Corrections should be restricted to typesetter errors and completion of in press references.

Substantial alterations to proofs may delay publication and also be charged to authors.

12. Offprints

Authors will be provided with electronic offprints of their paper. Paper offprints may be ordered at prices quoted on the order form, which accompanies proofs, provided that the form is returned with the proofs. The cost is more if the order form arrives too late for the main print run. Offprints are normally dispatched within three weeks of publication of the issue in which the paper appears. Please contact the publisher if offprints do not arrive: however, please note that offprints are sent by surface mail, so overseas orders may take up to six weeks to arrive. Electronic offprints are sent to the first author at his or her first e-mail address on the title page of the paper, unless advised otherwise; therefore please ensure that the name, address and email of the receiving author are clearly indicated on the manuscript title page if he or she is not the first author of the paper.

13. Exclusive Licence Form

Authors will be required to sign an Exclusive Licence Form (ELF) for all papers accepted for publication. Signature of the ELF is a condition of publication and papers will not be passed to the publisher for production unless a signed form has been received. Please note that signature of the Exclusive Licence Form does not affect ownership of copyright in the material. (Government employees need to complete the Author Warranty sections, although copyright in such cases does not need to be assigned). After submission authors will retain the right to publish their paper in various medium/circumstances (please see the form for further details). To assist authors an appropriate form will be supplied by the editorial office. Alternatively, authors may like to download a copy of the form here.

Contributors to this journal may choose to make their articles open access and available free for all readers. For options, see: http://www.interscience.wiley.com/openaccess

OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://www3.interscience.wiley.com/authorresources/onlineopen.html#OnlineOpen_Terms.

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at:

www.blackwellpublishing.com/pdf/JNC_OOF.pdf

Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

The copyright statement for OnlineOpen authors will read:

© [date] The Author(s)

Journal compilation © [date] International Society for Neurochemistry

Please note that if an article includes material which has already been published it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce in the article (in all media including print and electronic form) material not owned by the author(s), and to provide full acknowledgement of the source.

14. Inquiries concerning papers in press

Once authors have been informed that manuscripts have been accepted for publication, all inquiries concerning the status of manuscripts should be directed to: Production Editors, Journal of Neurochemistry, Wiley-Blackwell, 101 George Street, Edinburgh EH2 3ES, UK (email: jnc@wiley.com)

Online production tracking is now available for your article through Wiley-Blackwell's Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more. Digitisation of JNC: Wiley-Blackwell and The International Society for Neurochemistry have digitised the entire run of JNC back to volume one, issue one.

The back files, which have been defined as all of those issues published before 1997, will be sold to libraries as part of Wiley-Blackwell's Publishing's Legacy Sales Programme and hosted on the Wiley Interscience website.

NIH funded authors and Journal of Neurochemistry

The NIH mandates grantees to deposit their peer-reviewed author manuscripts in PubMed Central, to be made publicly available within 12 months of publication. The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008. In order to help authors comply with the NIH mandate, for papers accepted for publication in Journal of Neurochemistry, Wiley-Blackwell will post the accepted manuscript (incorporating all amendments made during peer review, but prior to the publisher's copy-editing and typesetting) of articles by NIH grant-holders to PubMed Central at the point of acceptance by the journal. This version will then be made publicly available in PubMed Central 12 months after publication. Following the deposit Wiley-Blackwell authors will receive further communications from the NIH with respect to the submission. For further information, see here.

If authors wish to make their final published article openly accessible and without a 12 month embargo, they can choose to publish via the OnlineOpen service.

Wellcome and HHMI grantees can find out further information here.